In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

Abhishek Pandurang Benke’s innovative leadership in managing complex multi-regional regulatory submissions has set new ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

The move aims to eliminate duplication, reduce compliance burdens on exporters, and ensure consistency with global serialization standards.

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...

The Commerce Ministry has withdrawn the track and trace provisions for pharmaceutical exports, aligning with the Ministry of Health’s regulations under Drug Rules 1945. The system, initiated in 2011, ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

India’s Directorate General of Foreign Trade (DGFT) has withdrawn its Track and Trace System for pharmaceutical exports under the Foreign Trade Policy effective 1st February 2025.This is to align ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

Direct-to-consumer advertising can be a controversial topic in the pharma industry. While the US isn’t the only other country ...